Compounds > xanthenes
Page last updated: 2024-08-18

xanthenes and Heart Failure

xanthenes has been researched along with Heart Failure in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's4 (36.36)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blaxall, BC; Kamal, FA; Lorenz, JN; Molkentin, JD; Nieman, ML; Sargent, MA; Travers, JG; Valiente-Alandi, I1
Arumugam, S; Bajpai, A; Bhimaraj, A; Giridharan, VV; Guha, A; Kamal, F; Karmouty-Quintana, H; Karuppagounder, V; Meng, S; Palaniyandi, SS; Spiller, KL; Sreedhar, R; Thandavarayan, RA; Watanabe, K; Youker, KA1
Francis, GS; Hall, JL; O'Connell, TD1
Blaxall, BC; Hammes, SR; Kamal, FA; Mickelsen, DM; Moalem, J; Smrcka, AV; Travers, JG; Wegman, KM1
Bernardo, BC; Blaxall, BC1
Belmonte, SL; Blaxall, BC; Casey, LM; Dunaevsky, O; Lopes, CM; Matavel, A; Migdalovich, D; Nwakanma, FE; Pistner, AR; Smrcka, AV; Stolpnik, O; Vorobiof, G1
Benkusky, N; Fiset, C; Glascock, B; Lalli, MJ; Periasamy, M; Plank, DM; Ritsu, H; Sussman, MA; Valdivia, HH; Witt, S; Yatani, A1
Chen, W; He, J; Leng, X; Liao, X; Liu, J; Ma, H; Mai, W; Tao, J; Wang, L; Zhen, W1
Elgner, A; Hasenfuss, G; Kettlewell, S; Kockskämper, J; Kögler, H; Maier, LS; Pieske, B; Raddatz, D; Ramadori, G; Schillinger, W; Schöndube, FA; Schwörer, H; Smith, GL; Sossalla, S; Tenderich, G; Teucher, N; Werner, C1
Gupta, A; Gupta, S; Mahajan, A; Maitra, RK; Popovic, ZB; Sen, S; Wang, Q; Yong, SL; Young, D1
Sánchez, A1

Reviews

2 review(s) available for xanthenes and Heart Failure

ArticleYear
From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart Failure.
    Heart, lung & circulation, 2016, Volume: 25, Issue:5

    Topics: Angiotensin Receptor Antagonists; Cardiac Myosins; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclohexanes; G-Protein-Coupled Receptor Kinase 2; Heart Failure; Humans; Neprilysin; Oximes; Paroxetine; Piperidines; RNA, Untranslated; Xanthenes

2016
[Depletion therapy of chronic congestive heart failure].
    Revista espanola de cardiologia, 1968, Volume: 21, Issue:2

    Topics: Bloodletting; Carbonic Anhydrase Inhibitors; Chlorides; Diet, Sodium-Restricted; Digitalis Glycosides; Diuresis; Diuretics; Ethacrynic Acid; Furosemide; Heart Failure; Humans; Hyperkalemia; Hypokalemia; Hyponatremia; Kidney Glomerulus; Kidney Tubules; Mineralocorticoid Receptor Antagonists; Organomercury Compounds; Spironolactone; Steroids; Thiazines; Triamterene; Uracil; Vasopressins; Water-Electrolyte Balance; Xanthenes

1968

Other Studies

9 other study(ies) available for xanthenes and Heart Failure

ArticleYear
Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Journal of the American College of Cardiology, 2017, Aug-22, Volume: 70, Issue:8

    Topics: Animals; Disease Models, Animal; Disease Progression; G-Protein-Coupled Receptor Kinase 2; Heart Failure; Mice; Mice, Knockout; Myocardial Ischemia; Myocardium; Myofibroblasts; Ventricular Remodeling; Xanthenes

2017
Small molecule disruption of G protein βγ subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats.
    PloS one, 2018, Volume: 13, Issue:7

    Topics: Animals; Autoimmune Diseases; G-Protein-Coupled Receptor Kinase 2; GTP-Binding Protein beta Subunits; GTP-Binding Protein gamma Subunits; Heart Failure; HMGB1 Protein; Humans; Macrophage Activation; Macrophages; Male; Myocarditis; Rats, Inbred Lew; Signal Transduction; Xanthenes

2018
Promising small molecule for heart failure targeting adrenal catecholamine release and β-adrenergic receptor signaling in the heart.
    Journal of the American College of Cardiology, 2014, Jun-17, Volume: 63, Issue:23

    Topics: Adrenal Glands; Animals; G-Protein-Coupled Receptor Kinase 2; Heart; Heart Failure; Humans; Male; Myocardium; Xanthenes

2014
Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.
    Journal of the American College of Cardiology, 2014, Jun-17, Volume: 63, Issue:23

    Topics: Adrenal Glands; Animals; Cells, Cultured; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; G-Protein-Coupled Receptor Kinase 2; Heart; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Stroke Volume; Treatment Outcome; Xanthenes

2014
Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure.
    Circulation research, 2010, Aug-20, Volume: 107, Issue:4

    Topics: Animals; Cyclohexanes; Disease Progression; Female; GTP-Binding Protein beta Subunits; GTP-Binding Protein gamma Subunits; Heart Failure; HL-60 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Signal Transduction; Xanthenes; Xenopus

2010
Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:1

    Topics: Adrenergic beta-Antagonists; Aniline Compounds; Animals; Blotting, Western; Calcium; Calcium Signaling; Calcium-Transporting ATPases; Carrier Proteins; Electrophysiology; Fluorescent Dyes; Heart Failure; Homeodomain Proteins; Membrane Potentials; Mice; Mice, Transgenic; Microfilament Proteins; Muscle Cells; Myocardial Contraction; Myocardium; Nuclease Protection Assays; Patch-Clamp Techniques; Propranolol; Ryanodine; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tropomodulin; Ventricular Remodeling; Xanthenes

2003
Angiotensin-converting enzyme inhibitor improves force and Ca2 +--frequency relationships in myocytes from rats with heart failure.
    Acta cardiologica, 2007, Volume: 62, Issue:2

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aniline Compounds; Animals; Blotting, Western; Calcium-Binding Proteins; Disease Models, Animal; Fluorescent Dyes; Heart Failure; Heart Ventricles; Male; Microscopy, Confocal; Myocardial Contraction; Myocytes, Cardiac; Perindopril; Random Allocation; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Calcium Exchanger; Xanthenes

2007
Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms.
    Circulation, 2007, Jul-03, Volume: 116, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Actin Cytoskeleton; Aniline Compounds; Animals; Anti-Ulcer Agents; Calcium; Calcium Channels, L-Type; Calcium Signaling; Depression, Chemical; Diastole; Female; Fluoresceins; Fluorescent Dyes; Heart Atria; Heart Failure; Heart Ventricles; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Ion Transport; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Oxalates; Pantoprazole; Patch-Clamp Techniques; Polymerase Chain Reaction; Proton Pump Inhibitors; Proton Pumps; Rabbits; Sarcoplasmic Reticulum; Systole; Xanthenes

2007
Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.
    Journal of molecular biology, 2008, Jan-18, Volume: 375, Issue:3

    Topics: Aging; Animals; Cardiomegaly; Disease Progression; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Silencing; Heart Failure; I-kappa B Kinase; Indoles; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence; NF-kappa B; Organ Specificity; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Transcription Factor RelA; Xanthenes

2008